RE: c-erbB-2/HER/neu
<< Previous Message | Next Message >>
From: | "Sebree Linda A." <la.sebree@hosp.wisc.edu> |
To: | "'Lapin sairaanhoitopiirin ky'" <paivi.sortti@lshp.fi> |
Reply-To: | |
Date: | Thu, 03 Jun 1999 14:46:03 -0500 |
Content-Type: | text/plain; charset="iso-8859-1" |
Hi Paivi,
We are using Neomarkers HER-2neu at a 1:75 dilution and employ a 20" HIER in
1mM EDTA at pH 8. Staining takes place on Ventana immunostainers with the
primary Ab being followed by a 1:200 RxM IgG to amplify the signal. Primary
incubation is for 32". We are not using this clinically (FISH instead) but
rather for a large breast carcinoma in situ study.
Feel free with any other questions,
Linda
Linda Sebree, HT
University of Wisconsin Hospital & Clinics
Department of Laboratory Medicine
IHC/ISH Laboratory
A4/204-2472
600 Highland Ave.
Madison, WI 53792-2472
Phone: (608)265-6596
FAX: (608)263-1568
> -----Original Message-----
> From: Lapin sairaanhoitopiirin ky [SMTP:paivi.sortti@lshp.fi]
> Sent: Thursday, June 03, 1999 8:14 AM
> To: 'histonetters'
> Subject: c-erbB-2/HER/neu
>
> Dear Netters,
>
> we are still looking for the ideal staining of c-erbB-2/HER/neu on breast
> cancer. We have the LabVision/Dako - autostainer and Ultravision detection
> system.
>
> What antibody are you using?
>
>
>
> Päivi Sortti
> LKS/pat.os
> puh: 016-328 4811
> fax: 016-328 4704
>
<< Previous Message | Next Message >>